Kozak & Associates’s Diageo DEO Stock Holding History

Kozak & Associates’s Portfolio DEO Stock Details DEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-39	Closed	-$4.31K	–	480
2025 Q1	$4.31K	Hold	39	–	–	﹤0.01%	305
2024 Q4	$4.73K	Buy	+39	New	+$4.96K	﹤0.01%	296

Other funds holding DEO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Markel Group Glen Allen, Virginia $11.9B AUM 10.84% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kozak & Associates's DEO Position: Q2 2025 in Review

Kozak & Associates sold out of Diageo (DEO) in Q2 2025, closing a stake of 39 shares — an estimated $4.31K sold.

Kozak & Associates first reported a position in DEO in Q4 2024 and held it in 2 quarters. The position peaked at $4.73K in Q4 2024. 852 funds tracked by Wall St. Rank hold DEO as of Q2 2025.

Kozak & Associates reported no remaining Diageo position as of Q2 2025 after selling out during the quarter.
Kozak & Associates sold 39 Diageo shares in Q2 2025, an estimated $4.31K.
Kozak & Associates first reported a position in Diageo in Q4 2024 and held it in 2 quarters.
Kozak & Associates's Diageo position peaked at $4.73K in Q4 2024.
852 funds tracked by Wall St. Rank held Diageo as of Q2 2025.

Based on Kozak & Associates's 13F filing for Q2 2025, filed 10 Jul 2025.